“The OxC-beta pet product is a breakthrough because of its proven results to optimize overall health. It’s like the discovery of a new class of vitamins—it’s unique, affordable and easy, prompting an increase in sales worldwide.”
– Jolyon Burton
President and Head of Investment Banking, Bloom Burton & Co.
News & Media
Avivagen Secures New Influential Customer in Mexico
Ottawa, ON /Business Wire/ March 8, 2022 /– Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and
Avivagen Announces Approval in Vietnam
Ottawa, ON /Business Wire/ February 22, 2022 /– Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing
Avivagen Announces CEO Update to Shareholders
Ottawa, ON /Business Wire/ January 26, 2022 /– Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”), a life sciences corporation
Avivagen has developed and is commercializing naturally-derived flavoring agents that help optimize feed intake which promotes health in livestock.
Avivagen offers its commercial partners scientifically backed, evidence-based products which are in high demand from multiple channels including veterinarians, farmers and producers, pet owners and retailers.
Avivagen maintains the highest manufacturing standards and is a proud member of the NASC, a self-regulating body, which protects and enhances the integrity of the animal health product industry.
Avivagen is actively collaborating with companies in Canada, the United States, the Philippines, Korea, Vietnam, and Thailand, and we are seeking more relationships internationally.
